Govt Job: For M.Pharm, M.Sc, M.Tech as Senior Research Fellow at AIIMS

The All-India Institute of Medical Sciences (AIIMS) was established as an institution of national importance by an Act of Parliament with the object of developing patterns of teaching in undergraduate and post-graduate medical education in all its branches so as to demonstrate a high standard of medical education in India; bringing together in one place educational facilities of the highest order for the training of personnel in all important branches of health activity, and attaining self-sufficiency in post-graduate medical education.

Senior Research Fellow (SRF).

Applications are invited from interested candidates to fulfill the vacancy of one Senior Research Fellow (SRF) post in an ICMR-funded project, on a purely temporary basis.

Awareness of head injury while driving in patients with epilepsy (PWE): A preventive and public educational study (1-1067; 2019-2023)”

Salary: As per ICMR guidelines

Project Duration: Till Jan 2023
Age35 years

Eligibility
Essential :
1. M.Sc. (Life Sciences), MA (Social Science), and Master in Medical Social Work (MSW) degree holders. OR

2. MBBS / BDS / MVSc / M.Pharma / ME / M.Tech degree holders. With Two years of Research

Experience:
Desirable: Candidates with Medical backgrounds and previous Research Experience in Neurology will be preferred.

Interested candidates are requested to send their up-to-date curriculum vitae to aiimsneuroproject@gmail.com clearly mentioning the subject “Application for the post of SRF position for ICMR project”. Only shortlisted candidates will be called for an interview.

The last date to send curriculum vitae is 11.08.2022.

Related Posts

Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

Andelyn bio sciences Inc, a leading patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered with Queen’s University to develop and manufacture AAV9-GM2, a gene therapy…

Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

Cellution Biologics Inc, a biologics company focused on developing, manufacturing and commercializing advanced human tissue-based products, announced the completion of its acquisition of the SimpliDerm hydrated human acellular dermal matrix…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

US appeals court sides with Sun Pharma in Lipitor antitrust case

US appeals court sides with Sun Pharma in Lipitor antitrust case

Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad

Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad